An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis.
- Tran, Huyen (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research